126 related articles for article (PubMed ID: 7542628)
1. Anti-immunoglobulin and anti-CD40 stimulation induces CD25 expression by resting human tonsillar B lymphocytes.
Burlinson EL; Pringle HM; Ozanne BW; Cushley W
Immunol Lett; 1995 Feb; 45(1-2):93-8. PubMed ID: 7542628
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of DRC-1 antigen.
Bosseloir AL; Antoine N; Heinen E; DeFrance T; Schuurman H; Simar L
Adv Exp Med Biol; 1994; 355():243-8. PubMed ID: 7535974
[No Abstract] [Full Text] [Related]
3. Soluble CD40 ligand induces expression of CD25 and CD23 in resting human tonsillar B lymphocytes.
Burlinson EL; Graber P; Bonnefoy JY; Ozanne BW; Cushley W
Eur J Immunol; 1996 May; 26(5):1069-73. PubMed ID: 8647169
[TBL] [Abstract][Full Text] [Related]
4. Activation of tumor necrosis factor-alpha and lymphotoxin-alpha via anti-CD40 in human B cells.
Worm M; Geha RS
Int Arch Allergy Immunol; 1995; 107(1-3):368-9. PubMed ID: 7542089
[No Abstract] [Full Text] [Related]
5. Interactions between IL-4, anti-CD40, and anti-immunoglobulin as activators of locomotion of human B cells.
Komai-Koma M; Liew FY; Wilkinson PC
J Immunol; 1995 Aug; 155(3):1110-6. PubMed ID: 7543514
[TBL] [Abstract][Full Text] [Related]
6. Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation.
Tuscano J; Engel P; Tedder TF; Kehrl JH
Blood; 1996 Jun; 87(11):4723-30. PubMed ID: 8639842
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells.
Kimata H; Yoshida A; Ishioka C; Lindley I; Mikawa H
J Exp Med; 1992 Oct; 176(4):1227-31. PubMed ID: 1383379
[TBL] [Abstract][Full Text] [Related]
9. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40.
Banchereau J; de Paoli P; Vallé A; Garcia E; Rousset F
Science; 1991 Jan; 251(4989):70-2. PubMed ID: 1702555
[TBL] [Abstract][Full Text] [Related]
10. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.
Gascan H; Gauchat JF; Aversa G; Van Vlasselaer P; de Vries JE
J Immunol; 1991 Jul; 147(1):8-13. PubMed ID: 1711085
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.
Rousset F; Garcia E; Banchereau J
J Exp Med; 1991 Mar; 173(3):705-10. PubMed ID: 1705282
[TBL] [Abstract][Full Text] [Related]
13. CD40 ligation induces lymphotoxin alpha gene expression in human B cells.
Worm M; Geha RS
Int Immunol; 1994 Dec; 6(12):1883-90. PubMed ID: 7535097
[TBL] [Abstract][Full Text] [Related]
14. Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule.
Lagresle C; Bella C; Daniel PT; Krammer PH; Defrance T
J Immunol; 1995 Jun; 154(11):5746-56. PubMed ID: 7538529
[TBL] [Abstract][Full Text] [Related]
15. A novel pathway of human B cell activation initiated by CK226 surface antigen.
Poggi A; Maggi E; Biagiotti R; Giudizi MG; Almerigogna F; Pella N; Caligaris-Cappio F; Romagnani S; Moretta L
Eur J Immunol; 1990 May; 20(5):1161-5. PubMed ID: 2141569
[TBL] [Abstract][Full Text] [Related]
16. Production of immunoglobulins by human sIgD+ and sIgD- human blood B lymphocytes in response to stimulation with activated T cells and agonistic antibodies; effect of IL-10, IL-2 and mode of activation of T cells.
Ling NR; Brown B; Hardie D
Clin Exp Immunol; 1995 Aug; 101(2):369-75. PubMed ID: 7544253
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking.
Kindler V; Matthes T; Jeannin P; Zubler RH
Eur J Immunol; 1995 May; 25(5):1239-43. PubMed ID: 7539752
[TBL] [Abstract][Full Text] [Related]
18. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.
Burdin N; Van Kooten C; Galibert L; Abrams JS; Wijdenes J; Banchereau J; Rousset F
J Immunol; 1995 Mar; 154(6):2533-44. PubMed ID: 7533177
[TBL] [Abstract][Full Text] [Related]
19. Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40.
Gordon J; Millsum MJ; Flores-Romo L; Gillis S
Immunology; 1989 Dec; 68(4):526-31. PubMed ID: 2481643
[TBL] [Abstract][Full Text] [Related]
20. Recombinant interleukin-4 promotes expression of the CD25 (Tac) antigen at the plasma membrane of high-density human tonsillar B lymphocytes.
Butcher RD; McGarvie GM; Cushley W
Immunology; 1990 Jan; 69(1):57-64. PubMed ID: 2179130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
